| 000 | 01732 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516170305.0 | ||
| 264 | 0 | _c20150109 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1748-717X | ||
| 024 | 7 |
_a10.1186/1748-717X-8-209 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRojas-Puentes, Luis L | |
| 245 | 0 | 0 |
_aPhase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases. _h[electronic resource] |
| 260 |
_bRadiation oncology (London, England) _cSep 2013 |
||
| 300 |
_a209 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBrain Neoplasms _xmortality |
| 650 | 0 | 4 |
_aChemoradiotherapy _xadverse effects |
| 650 | 0 | 4 |
_aChloroquine _xtherapeutic use |
| 650 | 0 | 4 |
_aCranial Irradiation _xadverse effects |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aRadiation-Sensitizing Agents _xtherapeutic use |
| 700 | 1 | _aGonzalez-Pinedo, Marcelino | |
| 700 | 1 | _aCrismatt, Alejando | |
| 700 | 1 | _aOrtega-Gomez, Alette | |
| 700 | 1 | _aGamboa-Vignolle, Carlos | |
| 700 | 1 | _aNuñez-Gomez, Rodrigo | |
| 700 | 1 | _aDorantes-Gallareta, Yusmiren | |
| 700 | 1 | _aArce-Salinas, Claudia | |
| 700 | 1 | _aArrieta, Oscar | |
| 773 | 0 |
_tRadiation oncology (London, England) _gvol. 8 _gp. 209 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1748-717X-8-209 _zAvailable from publisher's website |
| 999 |
_c23065308 _d23065308 |
||